Furthermore, MIDY pigs provide an interesting model for testing if diabetes treatments, e.g. insulin replacement therapies or SGLT2 (also known as SLC5A2) inhibitors, can revert the observed pulmonary alterations. Here, SLC5A2 is linked to diabetes mellitus.